Status:
COMPLETED
Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability
Lead Sponsor:
Markus Schlemmer
Conditions:
Anxiety Symptoms
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Bryophyllum pinnatum (BP) is a succulent perennial plant from the family Crassulacea (for reviews see Fürer 2016 and Hamburger 2017). Leaf extracts from BP have been used in traditional medicine to tr...
Detailed Description
The present IIT (Investigator-Initiated Trial) study is a prospective, single-group, pre-post study (phase IV). A past study showed that among Anthroposophical physicians the most frequent diagnosis ...
Eligibility Criteria
Inclusion
- Patients referred by their treating physician to the Department of Psychiatry and Psychosomatic of the Clinic Arlesheim waiting for the in-stay
- Expected waiting time until in-stay is at least two weeks
- Patients having anxiety symptoms as measured by the GAD-2 questionnaire (cut-off of 3 points)
- Patients'state of health allows them to complete the questionnaire on their own
- Signed informed consent
- No treatment with BP during the last two months
- No planned doses increase of (conventional) anxiolytics or antidepressants for the duration of the period until in-stay
- Age over 18 years
- Good German knowledge (at least level B2 from Common European Framework of Reference for Languages)
Exclusion
- Wheat allergies
- Acute life-threatening conditions
- Withdrawal of informed consent
Key Trial Info
Start Date :
August 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04825171
Start Date
August 31 2021
End Date
December 31 2023
Last Update
June 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik Arlesheim
Arlesheim, Basel-Landschaft, Switzerland, 4144